| [1] | Liver International｜MASLD, At-Risk MASH and increased liver stiffness are associated with young adulthood obesity without residual risk after losing obesity[J]. Journal of Clinical Hepatology, 2025, 41(2): 400-400. doi: 10.12449/JCH2502.gwqkjpwzjj4 |
| [2] | Yang ZHOU, Chaoxu FU, Min ZHOU, Lei XU, Mingyang LI, Yingsheng SHEN, Hongxin PIAO, Enyue YANG. Analysis of the results of hepatitis C antibody screening in 2020 in Yanbian area of China[J]. Journal of Clinical Hepatology, 2022, 38(7): 1509-1512. doi: 10.3969/j.issn.1001-5256.2022.07.011 |
| [3] | Dandan JIA, Guiying ZHU, Shiyao LIAO, Hui ZHANG, Hui GUO, Lili YANG, Changmiao WANG. Interpretation of European Society for Clinical Nutrition and Metabolism practical guideline : Clinical nutrition in liver disease (2020)[J]. Journal of Clinical Hepatology, 2021, 37(7): 1553-1557. doi: 10.3969/j.issn.1001-5256.2021.07.015 |
| [4] | Shengnan DU, Jingjing GAO, Tao WANG, Yuanye JIANG, Qin CAO. Value of circular RNA in the diagnosis and treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(11): 2684-2688. doi: 10.3969/j.issn.1001-5256.2021.11.043 |
| [5] | Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of Gastroenterology, Chinese Medical Association, Chinese Society of General Practice, Chinese Medical Association, Editorial Board of Chinese Journal of General Practitioners of Chinese Medical Association, Expert Group of Guidelines for Primary Care of Gastrointestinal Disease. Guideline for primary care of alcoholic liver disease(2019)[J]. Journal of Clinical Hepatology, 2021, 37(1): 36-40. doi: 10.3969/j.issn.1001-5256.2021.01.008 |
| [6] | Cao Yuan, Yao GuoXiang, Shi YiHai. An excerpt of international consensus guidelines for risk factors in chronic pancreatitis (2020)[J]. Journal of Clinical Hepatology, 2020, 36(8): 1720-1722. doi: 10.3969/j.issn.1001-5256.2020.08.008 |
| [7] | Zheng KeXin, Yang Ling, Qi XingShun. An excerpt of care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID expert consensus(2020)[J]. Journal of Clinical Hepatology, 2020, 36(5): 989-990. doi: 10.3969/j.issn.1001-5256.2020.05.007 |
| [8] | Zhu MengHua, He YingLi, Qi XingShun. An excerpt of management of patients with liver derangement during the COVID-19 pandemic: An Asia-Pacific position statement[J]. Journal of Clinical Hepatology, 2020, 36(10): 2197-2198. doi: 10.3969/j.issn.1001-5256.2020.10.007 |
| [9] | Wu YanYan, Chen LiGang, Qi XingShun. An excerpt of alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)[J]. Journal of Clinical Hepatology, 2020, 36(3): 527-528. doi: 10.3969/j.issn.1001-5256.2020.03.010 |
| [10] | Wu TingFeng, Liao XianHua, Zhong BiHui. Epidemiology of nonalcoholic fatty liver disease in some regions of China[J]. Journal of Clinical Hepatology, 2020, 36(6): 1370-1373. doi: 10.3969/j.issn.1001-5256.2020.06.039 |
| [11] | Zhang XiaXia, Xu YouQing. An excerpt of the recommendations of international liver transplantation society for management and treatment of nonalcoholic steatohepatitis (2018)[J]. Journal of Clinical Hepatology, 2019, 35(1): 64-66. doi: 10.3969/j.issn.1001-5256.2019.01.011 |
| [12] | Shang LanLan, Chen XiaoYing, Li JunFeng, Chen Hong. An excerpt of International Liver Transplantation Society Asian consensus on the management of hepatitis C virus infection in resource limited setting—From noncirrhotic to decompensated disease and following liver transplantation [J]. Journal of Clinical Hepatology, 2019, 35(2): 303-308. doi: 10.3969/j.issn.1001-5256.2019.02.012 |
| [13] | Song Yang, Zhou Fei, Chen LiGang. An excerpt of EASL clinical practice guidelines: Management of alcohol-related liver disease (2018)[J]. Journal of Clinical Hepatology, 2018, 34(7): 1415-1419. doi: 10.3969/j.issn.1001-5256.2018.07.010 |
| [14] | Li Jie. Epidemiology characteristics of nonalcoholic fatty liver disease in Asia[J]. Journal of Clinical Hepatology, 2018, 34(12): 2515-2519. doi: 10.3969/j.issn.1001-5256.2018.12.006 |
| [15] | Liu YingLi, Zhang QiuZan. An excerpt of the Asia-Pacific Working Party on nonalcoholic fatty liver disease guidelines 2017[J]. Journal of Clinical Hepatology, 2017, 33(12): 2278-2282. doi: 10.3969/j.issn.1001-5256.2017.12.004 |
| [16] | Ding YuPing, Li Hai, Zhang Wen, Xia ShiHai, Bi Xun. Epidemiological characteristics of nonalcoholic fatty liver disease with elevated alanine aminotransferase and related risk factors[J]. Journal of Clinical Hepatology, 2017, 33(12): 2355-2360. doi: 10.3969/j.issn.1001-5256.2017.12.020 |
| [17] | Chang BinXia, Sun Ying, Teng GuangJu, Zhang Wei, Zhao Jun, Zou ZhengSheng, Li BaoSen. Interpretation of the practice guidelines for alcoholic liver disease by EASL in 2012 and AASLD in 2010[J]. Journal of Clinical Hepatology, 2015, 31(1): 30-34. doi: 10.3969/j.issn.1001-5256.2015.01.007 |
| [18] | Hu Na, Cheng Hao, Shi JunPing. Introduction to the AASLD/ACG/AGA practice guideline: Diagnosis and management of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2012, 28(7): 487-492. |
| [19] | Ceng MinDe. Introduction to the EASL Clinical Practical Guidelines: Management of alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(8): 565-568. |
| [20] | Huang YiWen, Yang XianXin, Chen PeiZhe, Gao YanHang. Overview of alcoholic liver disease in Taiwan [J]. Journal of Clinical Hepatology, 2010, 26(3): 247-248. |
DownLoad: